This randomized trial demonstrates enhanced data reuse in metabolomics, suggesting increased collaboration in scientific research.
Metabolomics investigates an extraordinarily broad chemical space and generates experimental data with substantial potential for reuse in chemistry, biology, and related fields. We developed MB-POST (https://repository.massbank.jp), a new metabolomics mass spectrometry data repository based on a concept distinct from that of existing platforms, to fully realize this potential. MB-POST implements a reanalysis-oriented metadata framework that captures the information essential for data reuse while providing a streamlined submission system that enables the rapid deposition of standardized metabolomics metadata together with experimental data. Since its public pilot release in December 2024, MB-POST has attracted strong community adoption, with more than 170 experimental projects deposited within its first year and a half. Thus, MB-POST provides a practical foundation for the large-scale reuse of metabolomics mass spectrometry data and represents a concrete step toward accelerating open and data-driven scientific research.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: